KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Edwards Lifesciences' Short-term Investments rose 5024.04% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 5024.04%. This contributed to the annual value of $930.7 million for FY2024, which is 8595.4% up from last year.
  • Per Edwards Lifesciences' latest filing, its Short-term Investments stood at $1.2 billion for Q3 2025, which was up 5024.04% from $789.4 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Short-term Investments ranged from a high of $1.2 billion in Q3 2025 and a low of $156.4 million during Q1 2021
  • For the 5-year period, Edwards Lifesciences' Short-term Investments averaged around $528.5 million, with its median value being $466.7 million (2023).
  • As far as peak fluctuations go, Edwards Lifesciences' Short-term Investments plummeted by 5752.31% in 2021, and later skyrocketed by 19731.46% in 2022.
  • Over the past 5 years, Edwards Lifesciences' Short-term Investments (Quarter) stood at $604.0 million in 2021, then dropped by 26.11% to $446.3 million in 2022, then grew by 12.14% to $500.5 million in 2023, then skyrocketed by 85.95% to $930.7 million in 2024, then grew by 24.25% to $1.2 billion in 2025.
  • Its Short-term Investments stands at $1.2 billion for Q3 2025, versus $789.4 million for Q2 2025 and $757.9 million for Q1 2025.